Journals / Retina-Vitreus / 2006 / Cilt: 14 - Sayı: 3

Blurred vision associated with celecoxib

Celecoxib ile ilişkili görme bulanıklığı

Pages
229–231
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Similar visual disturbances with the use of traditional nonsteroidal antiinflammatory drugs were discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Celecoxib, a specific inhibitör of cyclooxygenase-2, is used to treat the symptoms of artritis.
📊
Key Findings & Data:A-33 years old woman developed blurred vision associated with this agent and resolved on discontinuation of celecoxib.
💡
Conclusion & Impact:Similar visual disturbances with the use of traditional nonsteroidal antiinflammatory drugs were discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Anti-enflamatuvar ajanlar · steroid olmayan · Siklooksijenaz inhibitörleri

Abstract

Celecoxib, a specific inhibitör of cyclooxygenase-2, is used to treat the symptoms of artritis. A-33 years old woman developed blurred vision associated with this agent and resolved on discontinuation of celecoxib. Similar visual disturbances with the use of traditional nonsteroidal antiinflammatory drugs were discussed.

Özet

Celecoxib; artrit semptomlarını tedavi etmede kullanılan bir spesifik siklooksijenaz-2 ( COX-2) inhibitörüdür. Bu olgu sunumunda celecoxib kullanımından sonra başlayan, ilaç kesildikten sonra düzelen ve bulanık görme şikayeti olan 33 yaşında kadın hasta sunulmuş ve literatürde klasik nonsteroid antienflamatuvar ( NSAİ ) ilaç kullanımından sonra benzer görme problemleri olan hastalarla karşılaştırılarak tartışılmıştır.

🔖

Cite This Article

KAN, E., ÇELİKER, Ü., TURGUT, B. (2006). Blurred vision associated with celecoxib. Retina-Vitreus, Cilt: 14 - Sayı: 3, 229–231. https://ajindex.com/articles/307804

References (18)

  1. brune K, Beck WS.: Towards safer nonsteroidal anti-inflammatory drugs. Agents Actions. 1991;32:13-25
  2. Davies P, Bailey PJ,: Goldenberg MM and Ford-Hutchinson AW.The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol. 1984;2:335-357
  3. Merlie JP, Fagan D, Mudd J et al.: Isolation and characterization of sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J Biol Chem. 1988;263:3550-3553
  4. Masferrer JL, Zweifel BS, et al.: Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc Natl Acad Sci. 1994;91:3228-3232
  5. Penning TD, Talley JJ, Bertenshaw SR, et al.: Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] bezenesulfonamide (SC-58635, celecoxib). J Med Chem. 1997;40:1347-1365
  6. Lipsky PE, Isakson PC.: Outcome of spesific COX-2 inhibition in rheumatoid arthritis. J Rheumatol. 1997;24:9-14
  7. Needleman P.: In search of better NSAIDs. 9th International conference on prostaglandins and related compounds, Florence, Italy. 1994:6-10
  8. Lefkowith JB.: Cyclooxygenase-2 specifity and its clinical implications. Am J Med. 1999;106:43-50
  9. Seibert K, Zheing Y, Leahy K, et al.: Pharmacological and biochemical demonstration of the role of cyclooxygenase -2 in inflammation and pain. Proc Natl Acad Sci. 1994;91:12013-12017
  10. G D Searle & Co.: Celebrex (Celecoxib) package insert. Chicago IL. 1999
  11. Coulter DM, John Clark DW, et al.: Celecoxib, Rofecoxib and acute temporary visual impairment. BMJ. 2003;327:1214-1215
  12. Lund BC, Neiman RF.: Visual disturbance associated with celecoxib. Pharmacotherapy. 2001;21:114-115
  13. Coulter DM, John Clark DW, et al.: Disturbance of vision by COX-2 inhibitors. Expert Opinion on Drug Safety. 2004;3:607-614
  14. Nicastro NJ.: Visual disturbance associated with over-the-counter ibuprofen in three patients. Ann Ophtalmol. 1989;21:447-450
  15. Fraundfelder FT.: Interim report: National registry of possible drug-induced ocular side effects. Ophthalmology. 1980;87:87-90
  16. Collum LMT, Bowen DI.: Ocular side effects of ibuprofen. Br J Ophthalmol. 1971;55:472-477
  17. Haefliger IO, Meyer P, Flammer J,: The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? Surv Ophthalmol. 1994;39:123-132
  18. Bombardier C, Laine L, Reicin A. et al.: Compariso